A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (Suppl 1) , S27-S34
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDGCancer, 2008
- 6-l-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical ApplicationsJournal of Nuclear Medicine, 2008
- Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumoursEuropean Journal of Cancer, 2007
- Surgery on neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Management and Treatment of Pheochromocytomas and ParagangliomasAnnals of the New York Academy of Sciences, 2006
- ParagangliomasAnnals of the New York Academy of Sciences, 2006
- Metastatic Carcinoid Tumors: A Clinical ReviewThe Oncologist, 2005
- Pheochromocytoma: State-of-the-Art and Future ProspectsEndocrine Reviews, 2003
- MANAGEMENT OF HEREDITARY PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU KINDREDS WITH PARTIAL ADRENALECTOMYJournal of Urology, 1999
- In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomasThe Journal of Clinical Endocrinology & Metabolism, 1992